HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, A. Y.-M. Articles by Woo, J. Search for Related Content PubMed PubMed Citation Articles by Wang, A. Y.-M. Articles by Woo, J. Agricola Articles by Wang, A. Y.-M. Articles by Woo, J.

Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study^1,2,3

¹ From the Departments of Medicine and Therapeutics (AY-MW, JES, MW, S-FL, MM-MS, and JW) and Chemical Pathology (CW-KL and IH-SC), The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong

Background:Patients with kidney disease are at high risk of developing 25-hydroxyvitamin D [25(OH)D] deficiency.

Objective:We studied the association between serum 25(OH)D status and clinical outcomes of chronic peritoneal dialysis patients.

Design:We measured serum 25(OH)D concentrations in 230 prevalent peritoneal dialysis patients and then followed these patients prospectively for 3 y or until death.

Results:Serum 25(OH)D was deficient or insufficient (ie, <75nmol/L) in 87% of the patients. Adjusting for clinical and demographic factors, every 1-unit increase in log-transformed serum 25(OH)D was associated with a 44% reduction in the hazard of fatal or nonfatal cardiovascular events (95% CI: 0.35, 0.91; P = 0.018). However, the association was gradually lost when additional adjustment was made in a stepwise fashion for residual glomerular filtration rate (P = 0.078) and echocardiographic measures (P = 0.39). Kaplan-Meier estimates showed a significantly greater fatal or nonfatal cardiovascular event-free survival probability among patients with serum 25(OH)D > 45.7 nmol/L (median) than among patients with concentrations 45.7 nmol/L (P = 0.004). In addition, patients with 25(OH)D > 45.7 nmol/L had a significantly higher cardiovascular event-free survival probability than did patients with 25(OH)D 45.7 nmol/L in the stratified analysis for patients with left ventricular mass index less than the median (P = 0.013) or normal systolic function (P = 0.005).

Conclusions:A lower serum 25(OH)D concentration was associated with an increased risk of cardiovascular events in chronic peritoneal dialysis patients. Furthermore, serum 25(OH)D status appeared to show a differential influence on the cardiovascular outcomes of peritoneal dialysis patients depending on the degree of left ventricular hypertrophy and systolic dysfunction.

This article has been cited by other articles:

				D. V. Barreto, F. C. Barreto, S. Liabeuf, M. Temmar, F. Boitte, G. Choukroun, A. Fournier, and Z. A. Massy Vitamin D Affects Survival Independently of Vascular Calcification in Chronic Kidney Disease Clin. J. Am. Soc. Nephrol., June 1, 2009; 4(6): 1128 - 1135. [Abstract] [Full Text] [PDF]

				B. Piraino, E. Minev, J. Bernardini, and F. H. Bender DOES EXPERIENCE WITH PD MATTER? Perit. Dial. Int., May 1, 2009; 29(3): 256 - 261. [Full Text] [PDF]

				C. Fourtounas and J. G Vlachojannis Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients Am. J. Clinical Nutrition, January 1, 2009; 89(1): 436 - 436. [Full Text] [PDF]